Allspring Global Investments Holdings LLC reduced its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 21.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 950 shares of the medical instruments supplier's stock after selling 267 shares during the period. Allspring Global Investments Holdings LLC's holdings in Mettler-Toledo International were worth $1,145,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of MTD. GAMMA Investing LLC grew its position in Mettler-Toledo International by 11.2% in the first quarter. GAMMA Investing LLC now owns 327 shares of the medical instruments supplier's stock worth $386,000 after acquiring an additional 33 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in Mettler-Toledo International by 95.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock worth $2,600,000 after purchasing an additional 1,073 shares in the last quarter. Blue Trust Inc. increased its position in Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock worth $73,000 after buying an additional 52 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund bought a new position in Mettler-Toledo International during the first quarter valued at about $714,000. Finally, Asset Management One Co. Ltd. lifted its position in shares of Mettler-Toledo International by 7.8% in the first quarter. Asset Management One Co. Ltd. now owns 18,991 shares of the medical instruments supplier's stock worth $22,427,000 after buying an additional 1,382 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Mettler-Toledo International
In related news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director owned 283 shares in the company, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Gerry Keller sold 165 shares of the business's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider owned 94 shares in the company, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,827 shares of company stock valued at $2,371,208. 1.94% of the stock is currently owned by corporate insiders.
Mettler-Toledo International Trading Down 0.2%
Shares of NYSE MTD opened at $1,382.96 on Thursday. The firm has a market capitalization of $28.49 billion, a price-to-earnings ratio of 35.02, a PEG ratio of 4.16 and a beta of 1.37. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,438.46. The business has a fifty day simple moving average of $1,292.42 and a 200 day simple moving average of $1,200.70.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business's revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
MTD has been the topic of a number of analyst reports. Barclays increased their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an "overweight" rating in a report on Thursday, October 2nd. JPMorgan Chase & Co. increased their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a "neutral" rating in a report on Thursday, October 9th. Robert W. Baird boosted their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Citigroup lifted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday, August 21st. Finally, Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 7th. Five equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $1,336.50.
Get Our Latest Analysis on MTD
Mettler-Toledo International Profile
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Stories
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report